292 related articles for article (PubMed ID: 17174627)
1. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale.
Martin DO; Stolen KQ; Brown S; Yu Y; Christie C; Doshi SK; Smith JM; Gold MR; Day JD
Am Heart J; 2007 Jan; 153(1):7-13. PubMed ID: 17174627
[TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
3. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
4. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial.
Martin DO; Day JD; Lai PY; Murphy AL; Nayak HM; Villareal RP; Weiner S; Kraus SM; Stolen KQ; Gold MR
J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1317-25. PubMed ID: 22830441
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy: device-based medicine for heart failure.
Philippon F
J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
[TBL] [Abstract][Full Text] [Related]
6. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold M; Abraham WT; Daubert JC;
Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
[TBL] [Abstract][Full Text] [Related]
8. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
9. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
10. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
Pires LA; Abraham WT; Young JB; Johnson KM;
Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
[TBL] [Abstract][Full Text] [Related]
11. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
[TBL] [Abstract][Full Text] [Related]
12. Long-term retention of cardiac resynchronization therapy.
Knight BP; Desai A; Coman J; Faddis M; Yong P
J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of a randomized trial of biventricular pacing in Canada.
Bentkover JD; Dorian P; Thibault B; Gardner M
Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
16. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
17. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
[TBL] [Abstract][Full Text] [Related]
18. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
[TBL] [Abstract][Full Text] [Related]
19. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
20. Effect of cardiac resynchronization therapy on ventricular remodeling.
Auricchio A; Spinelli JC; Trautmann SI; Kloss M
J Card Fail; 2002 Dec; 8(6 Suppl):S549-55. PubMed ID: 12555172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
